RYAN SITTLER: Open Payments
NPI 1184248387 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,388 in 183 payments from 21 companies in 2025. Trend: 2023 $3,517 · 2024 $3,972 · 2025 $4,388
Food & beverage: $4,231Education: $157
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 20 | $558 |
| UCB, Inc. | 15 | $496 |
| ABBVIE INC. | 18 | $472 |
| LEO Pharma Inc. | 11 | $339 |
| PFIZER INC. | 22 | $333 |
| Galderma Laboratories, L.P. | 18 | $308 |
| Biofrontera Inc. | 11 | $296 |
| Regeneron Healthcare Solutions, Inc. | 10 | $275 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $259 |
| Janssen Biotech, Inc. | 12 | $252 |
Products named: Zoryve, Bimzelx, DUPIXENT, CIBINQO, TREMFYA, ANZUPGO, SKYRIZI, NEMLUVIO.
Industry payments across NV — which companies pay providers there.
